AxoGen has been awarded the 2014 Product Innovation Leadership Award for Peripheral Nerve Repair from research organization Frost & Sullivan in recognition for the development and commercialization of Avance® Nerve Graft. Following extensive independent research by Frost & Sullivan’s Best Practices team, Avance® Nerve Graft was honored for the unique features and benefits it offers to the peripheral nerve repair market. The Avance Nerve Graft is based in part on decelluarization technologies developed in the Schmidt Lab at the University of Texas at Austin.
Read more at MarketWatch.com.